vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与Mirion Technologies, Inc.（MIR）财务数据对比。点击上方公司名可切换其他公司
CLOVER HEALTH INVESTMENTS, CORP.的季度营收约是Mirion Technologies, Inc.的1.9倍（$487.7M vs $257.6M），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 27.5%），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（18.6% vs 11.5%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
Mirion Technologies是全球领先的辐射检测、监测与安全解决方案提供商，核心产品涵盖个人剂量测量系统、辐射成像设备及辐射风险管理软件，服务核电、医疗、国防、工业等多个核心领域，客户遍布北美、欧洲及亚太地区。
CLOV vs MIR — 直观对比
营收规模更大
CLOV
是对方的1.9倍
$257.6M
营收增速更快
CLOV
高出17.2%
27.5%
两年增速更快
CLOV
近两年复合增速
11.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $487.7M | $257.6M |
| 净利润 | $-49.3M | — |
| 毛利率 | — | 46.2% |
| 营业利润率 | -10.1% | 1.4% |
| 净利率 | -10.1% | — |
| 营收同比 | 44.7% | 27.5% |
| 净利润同比 | -123.2% | — |
| 每股收益（稀释后） | — | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVMIR
| Q1 26 | — | $257.6M | ||
| Q4 25 | $487.7M | $277.4M | ||
| Q3 25 | $496.6M | $223.1M | ||
| Q2 25 | $477.6M | $222.9M | ||
| Q1 25 | $462.3M | $202.0M | ||
| Q4 24 | $337.0M | $254.3M | ||
| Q3 24 | $331.0M | $206.8M | ||
| Q2 24 | $356.3M | $207.1M |
净利润CLOVMIR
| Q1 26 | — | — | ||
| Q4 25 | $-49.3M | $17.3M | ||
| Q3 25 | $-24.4M | $2.9M | ||
| Q2 25 | $-10.6M | $8.3M | ||
| Q1 25 | $-1.3M | $300.0K | ||
| Q4 24 | $-22.1M | $15.0M | ||
| Q3 24 | $-9.2M | $-13.6M | ||
| Q2 24 | $7.4M | $-11.7M |
毛利率CLOVMIR
| Q1 26 | — | 46.2% | ||
| Q4 25 | — | 48.8% | ||
| Q3 25 | — | 46.8% | ||
| Q2 25 | — | 46.0% | ||
| Q1 25 | — | 47.6% | ||
| Q4 24 | — | 48.1% | ||
| Q3 24 | 24.5% | 44.9% | ||
| Q2 24 | 30.3% | 47.0% |
营业利润率CLOVMIR
| Q1 26 | — | 1.4% | ||
| Q4 25 | -10.1% | 9.2% | ||
| Q3 25 | -4.9% | 3.3% | ||
| Q2 25 | -2.2% | 4.4% | ||
| Q1 25 | -0.3% | 4.3% | ||
| Q4 24 | -6.4% | 11.4% | ||
| Q3 24 | -2.7% | -0.8% | ||
| Q2 24 | 2.0% | 1.1% |
净利率CLOVMIR
| Q1 26 | — | — | ||
| Q4 25 | -10.1% | 6.2% | ||
| Q3 25 | -4.9% | 1.3% | ||
| Q2 25 | -2.2% | 3.7% | ||
| Q1 25 | -0.3% | 0.1% | ||
| Q4 24 | -6.6% | 5.9% | ||
| Q3 24 | -2.8% | -6.6% | ||
| Q2 24 | 2.1% | -5.6% |
每股收益（稀释后）CLOVMIR
| Q1 26 | — | $-0.01 | ||
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $0.00 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.3M | $397.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $308.7M | $1.9B |
| 总资产 | $541.0M | $3.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLOVMIR
| Q1 26 | — | $397.9M | ||
| Q4 25 | $78.3M | $412.3M | ||
| Q3 25 | — | $933.2M | ||
| Q2 25 | — | $262.6M | ||
| Q1 25 | — | $185.8M | ||
| Q4 24 | $194.5M | $175.2M | ||
| Q3 24 | $288.0M | $133.3M | ||
| Q2 24 | $254.8M | $122.2M |
总债务CLOVMIR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $444.8M | ||
| Q2 25 | — | $444.9M | ||
| Q1 25 | — | $686.6M | ||
| Q4 24 | — | $686.4M | ||
| Q3 24 | — | $685.1M | ||
| Q2 24 | — | $684.1M |
股东权益CLOVMIR
| Q1 26 | — | $1.9B | ||
| Q4 25 | $308.7M | $1.9B | ||
| Q3 25 | $340.9M | $1.8B | ||
| Q2 25 | $344.2M | $1.5B | ||
| Q1 25 | $336.1M | $1.5B | ||
| Q4 24 | $341.1M | $1.5B | ||
| Q3 24 | $342.2M | $1.5B | ||
| Q2 24 | $324.9M | $1.5B |
总资产CLOVMIR
| Q1 26 | — | $3.5B | ||
| Q4 25 | $541.0M | $3.6B | ||
| Q3 25 | $559.7M | $3.5B | ||
| Q2 25 | $575.0M | $2.7B | ||
| Q1 25 | $583.7M | $2.6B | ||
| Q4 24 | $580.7M | $2.6B | ||
| Q3 24 | $653.0M | $2.7B | ||
| Q2 24 | $674.2M | $2.6B |
负债/权益比CLOVMIR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.30× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.45× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-66.9M | $18.9M |
| 自由现金流经营现金流 - 资本支出 | $-69.0M | — |
| 自由现金流率自由现金流/营收 | -14.1% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-69.2M | — |
8季度趋势，按日历期对齐
经营现金流CLOVMIR
| Q1 26 | — | $18.9M | ||
| Q4 25 | $-66.9M | $73.0M | ||
| Q3 25 | $12.1M | $22.3M | ||
| Q2 25 | $5.4M | $12.4M | ||
| Q1 25 | $-16.3M | $35.6M | ||
| Q4 24 | $34.8M | $60.8M | ||
| Q3 24 | $50.0M | $17.1M | ||
| Q2 24 | $44.8M | $15.2M |
自由现金流CLOVMIR
| Q1 26 | — | — | ||
| Q4 25 | $-69.0M | $63.2M | ||
| Q3 25 | $11.4M | $13.0M | ||
| Q2 25 | $4.8M | $3.6M | ||
| Q1 25 | $-16.5M | $27.1M | ||
| Q4 24 | $33.3M | $49.1M | ||
| Q3 24 | $49.6M | $3.9M | ||
| Q2 24 | $44.4M | $4.1M |
自由现金流率CLOVMIR
| Q1 26 | — | — | ||
| Q4 25 | -14.1% | 22.8% | ||
| Q3 25 | 2.3% | 5.8% | ||
| Q2 25 | 1.0% | 1.6% | ||
| Q1 25 | -3.6% | 13.4% | ||
| Q4 24 | 9.9% | 19.3% | ||
| Q3 24 | 15.0% | 1.9% | ||
| Q2 24 | 12.5% | 2.0% |
资本支出强度CLOVMIR
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 3.5% | ||
| Q3 25 | 0.1% | 4.2% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.0% | 4.2% | ||
| Q4 24 | 0.5% | 4.6% | ||
| Q3 24 | 0.1% | 6.4% | ||
| Q2 24 | 0.1% | 5.4% |
现金转化率CLOVMIR
| Q1 26 | — | — | ||
| Q4 25 | — | 4.22× | ||
| Q3 25 | — | 7.69× | ||
| Q2 25 | — | 1.49× | ||
| Q1 25 | — | 118.67× | ||
| Q4 24 | — | 4.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
MIR
| Product | $197.0M | 76% |
| Service | $60.6M | 24% |
